Contact
Please use this form to send email to PR contact of this press release:
Nexcella, an Immix Biopharma Subsidiary, on Track to Dose NXC-201 Patients in United States
TO:
Please use this form to send email to PR contact of this press release:
Nexcella, an Immix Biopharma Subsidiary, on Track to Dose NXC-201 Patients in United States
TO: